NSEAnalysts/Institutional Investor Meet/Con. Call Updates7h ago
Artemis Medicare Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Artemis Medicare Services Limited has informed the Exchange about an Analysts/Institutional Investors Conference scheduled for November 17, 2026, at JM Financial Annual India Conference in Mumbai.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults6d ago
Artemis Medicare Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Artemis Medicare Services Limited has informed the Exchange about Transcript of Earnings Conference Call - Q2 and H1 FY27. The company's consolidated revenue from operations for Q2 FY27 was INR 311 crores, representing year-on-year growth of 13.2%. Profit after tax for the quarter was INR 31 crore, representing a year-on-year growth of 3.7%. The company's focus remains on better utilization of clinical capacity, managing operational costs, and improving the contribution from specialized procedures.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults2 Nov 2026
Artemis Medicare Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Artemis Medicare Services Limited has made available the audio recording of its earnings conference call for Q2 and H1 FY27 on its website.
NSECopy of Newspaper PublicationResults31 Oct 2026
Artemis Medicare Services Limited
Copy of Newspaper Publication
Artemis Medicare Services Limited has informed the Exchange about the publication of un-audited financial results for the quarter and half year ended September 30, 2026, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
NSEMonitoring Agency ReportFundraise30 Oct 2026
Artemis Medicare Services Limited
Monitoring Agency Report
Artemis Medicare Services Limited has received a Monitoring Agency Report for the quarter ended September 30, 2026, from CARE Ratings Limited, which has found no deviation from the objects of the Preferential Issue of ₹330 crore.
NSEInvestor PresentationResults30 Oct 2026
Artemis Medicare Services Limited
Investor Presentation
Artemis Medicare Services Limited has informed the Exchange about Investor Presentation for Q2 and H1 FY 27, highlighting its business overview, roadmap ahead, synergies, CSR initiatives, and ESG highlights.
NSEPress Release▲ PositiveResults30 Oct 2026
Artemis Medicare Services Limited
Press Release
Artemis Medicare Services Limited has announced its Q2 FY27 financial results, with consolidated revenue from operations up 13.2% year-on-year, and adjusted EBITDA up 22.7%. The company's Gurugram operations recorded revenue growth of 14.5% year-on-year, with improved occupancy and operating profitability.
NSEOutcome of Board MeetingResults30 Oct 2026
Artemis Medicare Services Limited
Outcome of Board Meeting
Artemis Medicare Services Limited has submitted its un-audited financial results for the quarter ended September 30, 2026, with the Board of Directors approving the results at its meeting held on October 30, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults27 Oct 2026
Artemis Medicare Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Artemis Medicare Services Limited has informed the Exchange about the schedule of Earnings Conference Call for Q2 and H1 FY27, to be held on November 2, 2026.
NSECertificate under SEBI (Depositories and Participants) Regulations, 20186 Oct 2026
Artemis Medicare Services Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Artemis Medicare Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the CompanyLitigation29 Sept 2026
Artemis Medicare Services Limited
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Artemis Medicare Services Limited has received a Show Cause Notice from the Office of the Assistant Commissioner, CGST, Gurugram regarding alleged non-payment of GST on medicines, consumables, and implants supplied to in-patients. The company has filed a writ petition before the Hon'ble High Court of Punjab & Haryana, Chandigarh, and is in the process of filing another writ to connect the matter with the previous one.
NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the CompanyLitigation29 Sept 2026
Artemis Medicare Services Limited
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Artemis Medicare Services Limited has received a Show Cause Notice from the Office of the Assistant Commissioner, CGST, Gurugram regarding alleged non-payment of GST on medicines, consumables, and implants supplied to in-patients. The company has filed a writ petition before the Hon'ble High Court of Punjab & Haryana, Chandigarh, and is in the process of filing another writ to connect the matter with the previous one.
NSETrading Window28 Sept 2026
Artemis Medicare Services Limited
Trading Window
Artemis Medicare Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
NSECredit RatingRating Change24 Sept 2026
Artemis Medicare Services Limited
Credit Rating
Artemis Medicare Services Limited has informed the Exchange about the reaffirmation of its credit rating by CARE Ratings Limited, with a stable outlook for its long-term bank facilities and short-term bank facilities.
NSECopy of Newspaper Publication15 Sept 2026
Artemis Medicare Services Limited
Copy of Newspaper Publication
Artemis Medicare Services Limited has published a newspaper advertisement regarding the opening of a special window for transfer and dematerialisation of physical securities, as per SEBI regulations.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesMgmt Change8 Sept 2026
Artemis Medicare Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Artemis Medicare Services Limited has informed the Exchange about an Analysts/ Institutional Investors Conference scheduled for September 22, 2026, at the Anand Rathi Annual Flagship Conference in Mumbai.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates27 Aug 2026
Artemis Medicare Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Artemis Medicare Services Limited has informed the Exchange about Analysts/ Institutional Investors' Conference - September 3, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026
Artemis Medicare Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Artemis Medicare Services Limited has informed the Exchange about Transcript of Earnings Conference Call - Q1 FY27. The company's consolidated revenue from operations for the quarter was at INR 287.32 crores, reflecting a year-on-year growth of 12.7% on a consolidated basis, and standalone year-on-year Gurgaon showed a top-line growth of 15.4%. The performance was supported by sustained demand across key specialties, particularly cardiology, oncology, neurosciences, and orthopedics, along with continued improvement in case mix and higher contribution from complex procedures.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates10 Aug 2026
Artemis Medicare Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Artemis Medicare Services Limited has informed the Exchange about Analysts/ Institutional Investors' Conference scheduled for August 13, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults4 Aug 2026
Artemis Medicare Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Artemis Medicare Services Limited has made available the audio recording of its Earnings Conference Call for Q1 FY27 on its website.